Every year, over 18,000 Australians are diagnosed with invasive melanoma and over 1,400 Australians will lose their life to this deadly cancer that can affect young and old.
Australian researchers have led the way in developing treatments for melanoma and skin cancer, and the last decade has seen remarkable breakthroughs. Clinical trials have played a critical part in this success.
The first wave of industry-driven innovation in melanoma and skin cancer treatments led by major pharmaceutical companies has receded. Although we now have a range of new therapies, we are still discovering how to optimally use these new treatments for patients and that is why our clinical trials are so important.
Give to help more Australians access clinical trials
Thanks to the work of Melanoma and Skin Cancer Trials over the past 25 years, more than 7,500 melanoma and skin cancer patients have accessed our clinical trials that may have improved their quality of life, prevented them from undergoing debilitating treatments, and for some, given them more time with loved ones.